A Randomised Controlled Feasibility Trial of Surgery versus No Surgery as Part of Multi-Modality Treatment in Stage III-N2 Non-Small Cell Lung Cancer

被引：0
|
作者：
Taylor, Sally [1 ]
Stanworth, Melissa [1 ]
Ward, Ashleigh [1 ]
Harris, Emily [1 ]
Tsim, Selina [2 ]
Navani, Neal [3 ]
Baldwin, David [4 ]
Woolhouse, Ian [5 ]
Edwards, John [6 ]
Grundy, Seamus [7 ]
Rhodes, Sarah [8 ]
Burnside, Nathan [4 ]
Blackhall, Fiona [1 ]
Faivre-Finn, Corinne [1 ]
Yorke, Janelle [1 ]
Evison, Matthew [9 ]
机构：
[1] Christie NHS Fdn Trust, Manchester, Lancs, England
[2] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland
[3] Univ Coll London Hosp, London, England
[4] Nottingham Univ Hosp NHS Trust, Nottingham, England
[5] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
[6] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England
[7] Salford Royal NHS Fdn Trust, Salford, Lancs, England
[8] Univ Manchester, Manchester, Lancs, England
[9] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England
来源：
LUNG CANCER | 2024年 / 190卷
关键词：
D O I：
10.1016/j.lungcan.2024.107698
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Combined modality therapy for stage III non-small cell lung cancer
    Stinchcombe, Thomas E.
    Fried, Daniel
    Morris, David E.
    Socinski, Mark A.
    ONCOLOGIST, 2006, 11 (07): : 809 - 823
  • [42] Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients
    Gao, Fei
    Li, Nan
    Xu, YongMei
    Yang, GuoWang
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [43] A prospective randomized study of adjuvant chemotherapy in completely resected stage III-N2 non-small cell lung cancer
    Zheng Shi Ying
    Jiang Dong
    Li Hong
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S518 - S518
  • [44] Systemic Inflammation-Immune Status Predicts Survival in Stage III-N2 Non-Small Cell Lung Cancer
    Wang, Jianyang
    Hui, Zhouguang
    Men, Yu
    Kang, Jingjing
    Sun, Xin
    Deng, Lei
    Zhai, Yirui
    Wang, Wenqing
    Bi, Nan
    Liang, Jun
    Lv, Jima
    Zhou, Zongmei
    Feng, Qinfu
    Xiao, Zefen
    Chen, Dongfu
    Wang, Luhua
    Zhao, Jun
    ANNALS OF THORACIC SURGERY, 2019, 108 (06): : 1701 - 1709
  • [45] The role of surgery in the treatment of stage III non-small-cell lung cancer
    Gallo A.M.
    Donington J.S.
    Current Oncology Reports, 2007, 9 (4) : 247 - 254
  • [46] The multimodality treatment of stage III a/b non-small cell lung cancer - The role of surgery, radiation, and chemotherapy
    Lee, JD
    Ginsberg, RJ
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (02) : 279 - +
  • [47] Keys to successful induction chemoradiotherapy followed by surgery for stage III/N2 non-small cell lung cancer
    Sata, Yuki
    Nakajima, Takahiro
    Yamamoto, Takayoshi
    Morimoto, Junichi
    Sakairi, Yuichi
    Wada, Hironobu
    Suzuki, Hidemi
    Yoshino, Ichiro
    SURGERY TODAY, 2019, 49 (07) : 547 - 555
  • [48] Keys to successful induction chemoradiotherapy followed by surgery for stage III/N2 non-small cell lung cancer
    Yuki Sata
    Takahiro Nakajima
    Takayoshi Yamamoto
    Junichi Morimoto
    Yuichi Sakairi
    Hironobu Wada
    Hidemi Suzuki
    Ichiro Yoshino
    Surgery Today, 2019, 49 : 547 - 555
  • [49] Surgery in stage III non-small-cell lung cancer
    Eberhardt, Wilfried E. E.
    Stamatis, Georgios
    Stuschke, Martin
    LANCET, 2009, 374 (9687): : 359 - 360
  • [50] Treatment of choice for stage I non-small cell lung cancer: Surgery or radiotherapy?
    Asamura, Hisao
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) : 766 - 767
12345